Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Monthly Communication Reports in: April 2020

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Hoffmann-La Roche Limited

RONNIE MILLER, PRESIDENT AND CHIEF EXECUTIVE OFFICER (Corporation)

Results 1-10 of 10

  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-04-28
    Posted date: 2020-05-11
    Communication number: 64-472253 View monthly communication report
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Celia Caira, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-28
    Posted date: 2020-05-11
    Communication number: 64-472252 View monthly communication report
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Products & Food Branch | Health Canada (HC)
    • Marc Mes, Director General | Marketed Health Products Directorate | Health Canada (HC)
    • Celia Lourenco, Director General | Biologic & Radiopharmaceutical Drugs Directorate | Health Canada (HC)
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)
    • Supriya Sharma, Chief Medical Officer | Health Canada (HC)
    • John Patrick Stewart, Director General | Therapeutic Products Directorate | Health Canada (HC)
    • Tammy Clifford, Vice President, Research Programs | Canadian Institutes of Health Research (CIHR)
    • Roman Szumski, Vice President, Life Sciences | National Research Council (NRC)

    Subject Matter of the communication: Health
    Communication date: 2020-04-28
    Posted date: 2020-05-11
    Communication number: 64-472251 View monthly communication report
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Products & Food Branch | Health Canada (HC)
    • Emmanuel Kamarianakis, Director General | Investment and Innovation | Global Affairs Canada (GAC)
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)
    • Charles Vincent, Director General | Automotive, Transportation & Digital Technologies | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-27
    Posted date: 2020-05-11
    Communication number: 64-472248 View monthly communication report
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-04-27
    Posted date: 2020-05-11
    Communication number: 64-472246 View monthly communication report
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jesse Fleming, Senior Director, Policy & Engagement | Programs Directorate | Environment and Climate Change Canada (ECCC)
    • James Burns, Director | Digital Technologies Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Dana Curley, Oversight Executive | Digital Investment Oversight Directorate | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-27
    Posted date: 2020-05-11
    Communication number: 64-472240 View monthly communication report
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-04-24
    Posted date: 2020-05-11
    Communication number: 64-472238 View monthly communication report
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Navdeep Bains, Minister of Innovation, Science and Industry | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-10
    Posted date: 2020-05-11
    Communication number: 64-472237 View monthly communication report
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Amanda Woodley, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-09
    Posted date: 2020-05-11
    Communication number: 64-472236 View monthly communication report
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament, Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-02
    Posted date: 2020-05-11
    Communication number: 64-472235 View monthly communication report

Return to Monthly Communication Reports by Reporting Period

Date Modified: